Form 4: VYNE Therapeutics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Iain Stuart, CHIEF SCIENTIFIC OFFICER of VYNE Therapeutics Inc., reported a transaction in 15,405 shares of common stock on July 23, 2026.
Summary
- Tax/exercise-price withholding: disposed of 15,405 Common Stock at $0.90 ($13,828) on July 23, 2026; holds 95,944 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Iain Stuart — Officer (CHIEF SCIENTIFIC OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-23 | Tax/exercise-price withholding | Common Stock | 15,405 | $1 | $13.8K | 95,944 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-23 | Tax/exercise-price withholding (15,405 shares) |
Keywords
insider transaction, Form 4, VYNE, VYNE Therapeutics Inc., neutral, Iain Stuart
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.